Pacific Biosciences of Ca...

NASDAQ: PACB · Real-Time Price · USD
1.13
0.13 (13.00%)
At close: Jun 06, 2025, 3:59 PM
1.12
-0.86%
After-hours: Jun 06, 2025, 05:55 PM EDT

Pacific Biosciences of California Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Consumable Revenue 70.37M 59.98M 52.18M 31.14M 32.62M 37.86M
Consumable Revenue Growth +17.33% +14.95% +67.56% -4.52% -13.86% n/a
Instrument Revenue 65.78M 48.72M 61.32M 34.28M 45.13M 28.49M
Instrument Revenue Growth +35.01% -20.55% +78.88% -24.03% +58.38% n/a
Product Revenue 136.15M 108.7M 113.5M 65.42M 77.74M 66.36M
Product Revenue Growth +25.25% -4.23% +73.49% -15.84% +17.16% n/a
Service And Other Revenue 17.86M 19.61M 17.01M 13.47M 13.15M 12.27M
Service And Other Revenue Growth -8.88% +15.27% +26.28% +2.43% +7.16% n/a

Revenue by Geography

Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2012
Americas Revenue 78.71M 36.15M 35.72M 22.55M 26.61M 29.07M 39.7M 11.4M
Americas Revenue Growth +117.76% +1.19% +58.40% -15.25% -8.46% -26.78% +248.25% n/a
Asia Pacific Revenue 40.71M n/a n/a n/a n/a n/a n/a n/a
Asia Pacific Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a
Emea Revenue 34.59M n/a n/a n/a n/a n/a n/a n/a
Emea Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a
United States Revenue 75.3M n/a n/a n/a n/a n/a n/a n/a
United States Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 40.17M 41.64M 43.75M 45.88M 42.41M 46M 43.43M 40.57M 39.82M 45M 36.8M 39.25M 39.8M 37.32M 31.61M 29.06M 26.14M 17.95M 14.77M 15.13M 24.95M 16.58M 20.07M 19.08M 19.77M 20.11M 13.51M 14.94M 14.93M 14.4M 13.95M 15.51M 15.27M 12.99M 11.89M 11.19M 11.71M 12.78M 10.82M 10.82M 10.77M
Selling, General, and Administrative Revenue Growth -3.54% -4.81% -4.65% +8.19% -7.81% +5.91% +7.04% +1.90% -11.52% +22.31% -6.26% -1.39% +6.66% +18.08% +8.76% +11.17% +45.60% +21.53% -2.35% -39.36% +50.50% -17.39% +5.15% -3.46% -1.69% +48.87% -9.62% +0.06% +3.73% +3.19% -10.02% +1.57% +17.49% +9.24% +6.27% -4.41% -8.36% +18.10% -0.03% +0.45% n/a
Research and Development Revenue 29.05M 27.47M 25.52M 38.48M 43.45M 44.54M 47.51M 46.17M 48.94M 42.62M 47.09M 50.35M 52.94M 42.58M 27.51M 22.27M 20.55M 17.43M 16.47M 15.01M 15.25M 14.27M 14.96M 14.91M 15.48M 16.26M 14.36M 15.66M 16.31M 15.63M 15.84M 16.88M 16.97M 16.25M 17.48M 17.52M 16.36M 14.75M 16.16M 15.04M 14.48M
Research and Development Revenue Growth +5.78% +7.64% -33.70% -11.44% -2.44% -6.25% +2.90% -5.65% +14.82% -9.49% -6.47% -4.89% +24.34% +54.78% +23.54% +8.36% +17.92% +5.82% +9.71% -1.57% +6.85% -4.60% +0.35% -3.71% -4.78% +13.28% -8.35% -3.97% +4.38% -1.38% -6.15% -0.52% +4.40% -7.00% -0.25% +7.10% +10.91% -8.72% +7.44% +3.87% n/a